The Patent Finder
US

Extended Length Botulinum Toxin Formulation for Human or Mammalian Use

US 9,950,042 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Botulinum Toxin Research Associates, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Collateral for a security interest recorded Feb 7, 2025 (Hayfin Services LLP).

Term ends Dec 4, 2029 · High confidence

Filed Jun 29, 2015 as application 14/754,268 · Granted Apr 24, 2018
Base term, 20 years from filing
Today
20 years from filing
2009 2029
Clock starts
Dec 4, 2009
Term ends
Dec 4, 2029
Granted
Apr 24, 2018
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 4, 2009, when application PCT/US2009/066891, the earliest non-provisional in its chain, was filed (this one was filed Jun 29, 2015)Dec 4, 2029High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderDec 4, 2029High confidence

This family

Application PCT/US2009/066891PCT application
no patent term
no patent term
US 9,066,851In force
Sep 2031
Sep 2031
US 9,950,042this patent
Dec 2029
Dec 2029
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Mar 24, 2016
Reel 38249, frame 590
Borodic, Gary e, DRBotulinum Toxin Research Associates, Inc.Assignment of Assignor's Interest
Jun 3, 2016
Reel 38870, frame 160
Botulinum Toxin Research Associates, Inc.Revance Therapeutics, Inc.Assignment of Assignor's Interest
Mar 18, 2022
Reel 59437, frame 654
Revance Therapeutics, Inc.Athyrium Buffalo LPSecurity Interest
Feb 7, 2025
Reel 70153, frame 630
Athyrium Buffalo LPRevance Therapeutics, Inc.Release of Security Interest
Feb 7, 2025
Reel 70153, frame 663
Revance Therapeutics, Inc.; Crown Laboratories, Inc.Hayfin Services LLP, as Administrative AgentSecurity Interest
Feb 7, 2025
Reel 70153, frame 736
Revance Therapeutics, Inc.; Bellus Medical, LLC; Crown Laboratories, Inc.Hayfin Services LLP, as Administrative AgentSecurity Interest
Feb 17, 2025
Reel 70239, frame 739
Revance Therapeutics, Inc.Jpmorgan Chase Bank, N.a.Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited